Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Volitionrx Ltd (VNRX) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Volitionrx Ltd. Table 2 shows the detailed insider transactions. This company's CIK number is 93314.
Total stock buying since 2015: $4,405,521.
Total stock sales since 2015: $799,973.
Total stock option exercises since 2015: $1,853,750.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 622,386 | $348,393 | 0 | $0 | 0 | $0 |
| 2024 | 595,648 | $355,409 | 20,000 | $18,000 | 0 | $0 |
| 2023 | 504,422 | $676,522 | 20,000 | $15,000 | 0 | $0 |
| 2022 | 539,089 | $1,089,126 | 24,949 | $64,424 | 0 | $0 |
| 2021 | 162,000 | $549,099 | 20,000 | $89,100 | 0 | $0 |
| 2020 | 4,000 | $11,000 | 99,500 | $322,634 | 435,000 | $1,189,250 |
| 2019 | 261,100 | $984,640 | 46,238 | $278,815 | 0 | $0 |
| 2018 | 61,500 | $120,865 | 0 | $0 | 0 | $0 |
| 2017 | 10,010 | $27,920 | 0 | $0 | 0 | $0 |
| 2016 | 10,000 | $50,000 | 3,390 | $12,000 | 338,000 | $514,000 |
| 2015 | 51,500 | $192,547 | 0 | $0 | 50,000 | $150,500 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 156,250 | $100,000 | 0 | $0 | 0 | $0 |
| 2025-06 | 32,500 | $18,155 | 0 | $0 | 0 | $0 |
| 2025-05 | 70,000 | $30,240 | 0 | $0 | 0 | $0 |
| 2025-03 | 363,636 | $199,998 | 0 | $0 | 0 | $0 |
| 2024-12 | 445,648 | $254,909 | 0 | $0 | 0 | $0 |
| 2024-08 | 150,000 | $100,500 | 0 | $0 | 0 | $0 |
| 2024-01 | 0 | $0 | 20,000 | $18,000 | 0 | $0 |
| 2023-12 | 50,000 | $37,000 | 20,000 | $15,000 | 0 | $0 |
| 2023-11 | 99,000 | $75,500 | 0 | $0 | 0 | $0 |
| 2023-09 | 5,000 | $6,500 | 0 | $0 | 0 | $0 |
| 2023-08 | 106,422 | $132,122 | 0 | $0 | 0 | $0 |
| 2023-06 | 10,000 | $15,900 | 0 | $0 | 0 | $0 |
| 2023-02 | 234,000 | $409,500 | 0 | $0 | 0 | $0 |
| 2022-12 | 141,089 | $306,481 | 0 | $0 | 0 | $0 |
| 2022-11 | 5,000 | $11,050 | 0 | $0 | 0 | $0 |
| 2022-09 | 13,000 | $22,100 | 0 | $0 | 0 | $0 |
| 2022-08 | 360,000 | $705,295 | 0 | $0 | 0 | $0 |
| 2022-06 | 10,000 | $20,500 | 14,949 | $36,924 | 0 | $0 |
| 2022-05 | 10,000 | $23,700 | 0 | $0 | 0 | $0 |
| 2022-04 | 0 | $0 | 10,000 | $27,500 | 0 | $0 |
| 2021-11 | 10,000 | $40,199 | 0 | $0 | 0 | $0 |
| 2021-05 | 152,000 | $508,900 | 10,000 | $35,400 | 0 | $0 |
| 2021-02 | 0 | $0 | 10,000 | $53,700 | 0 | $0 |
| 2020-12 | 0 | $0 | 10,000 | $34,000 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-01 | Innes Guy Archibald | Buy | 78,125 | .64 | 50,000 |
| 2025-08-01 | Reynolds Cameron John (President and CEO) | Buy | 78,125 | .64 | 50,000 |
| 2025-06-01 | Innes Guy Archibald | Buy | 20,000 | .54 | 10,780 |
| 2025-06-01 | Reynolds Cameron John (President and CEO) | Buy | 12,500 | .59 | 7,375 |
| 2025-05-01 | Micallef Jacob Vincent (Chief Scientific Officer) | Buy | 50,000 | .43 | 21,500 |
| 2025-05-01 | Reynolds Cameron John (President and CEO) | Buy | 20,000 | .44 | 8,740 |
| 2025-03-01 | Innes Guy Archibald | Buy | 181,818 | .55 | 99,999 |
| 2025-03-01 | Reynolds Cameron John (President and CEO) | Buy | 181,818 | .55 | 99,999 |
| 2024-12-01 | Micallef Jacob Vincent (Chief Scientific Officer) | Buy | 43,691 | .57 | 24,991 |
| 2024-12-01 | Innes Guy Archibald | Buy | 174,764 | .57 | 99,965 |
| 2024-12-01 | Reynolds Cameron John (President and CEO) | Buy | 139,811 | .57 | 79,971 |
| 2024-12-01 | Still Timothy I | Buy | 87,382 | .57 | 49,982 |
| 2024-08-01 | Innes Guy Archibald | Buy | 150,000 | .67 | 100,500 |
| 2024-01-02 | Hever Investments Ltd (10% Owner) | Sale | 20,000 | .90 | 18,000 |
| 2023-12-15 | Hever Investments Ltd (10% Owner) | Sale | 20,000 | .75 | 15,000 |
| 2023-12-01 | Butera Salvatore Thomas (CEO - Volition Veterinary) | Buy | 20,000 | .80 | 16,000 |
| 2023-12-01 | Rootsaert Rodney Gerard (Secretary) | Buy | 10,000 | .60 | 6,000 |
| 2023-12-01 | Reynolds Cameron John (President and CEO) | Buy | 10,000 | .67 | 6,700 |
| 2023-11-01 | Butera Salvatore Thomas (CEO - Volition Veterinary) | Buy | 10,000 | .81 | 8,100 |
| 2023-11-01 | Innes Guy Archibald | Buy | 50,000 | .75 | 37,200 |
| 2023-11-01 | Futcher Edward | Buy | 9,000 | .80 | 7,200 |
| 2023-09-01 | Barnes Phillip | Buy | 5,000 | 1.30 | 6,500 |
| 2023-08-01 | Henshall Mickie | Buy | 3,706 | 1.25 | 4,632 |
| 2023-08-01 | Butera Salvatore Thomas (CEO - Volition Veterinary) | Buy | 8,000 | 1.21 | 9,680 |
| 2023-08-01 | Kway Jasmine (CEO - Singapore Volition) | Buy | 5,000 | 1.20 | 6,000 |
| 2023-08-01 | Michel Gaetan (Chief Operating Officer) | Buy | 5,000 | 1.23 | 6,150 |
| 2023-08-01 | Micallef Jacob Vincent (Chief Scientific Officer) | Buy | 40,000 | 1.25 | 49,862 |
| 2023-08-01 | Faulkes Martin Charles | Buy | 9,716 | 1.28 | 12,436 |
| 2023-08-01 | Reynolds Cameron John (President and CEO) | Buy | 10,000 | 1.22 | 12,200 |
| 2023-08-01 | Futcher Edward | Buy | 5,000 | 1.22 | 6,100 |
| 2023-06-01 | Butera Salvatore Thomas (CEO - Volition Veterinary) | Buy | 10,000 | 1.59 | 15,900 |
| 2023-02-01 | Innes Guy Archibald | Buy | 234,000 | 1.75 | 409,500 |
| 2022-12-01 | Plummer Nicholas (GC - Volition Diagnostics) | Buy | 9,600 | 2.07 | 19,872 |
| 2022-12-01 | Butera Salvatore Thomas (CEO - Volition Veterinary) | Buy | 9,350 | 2.18 | 20,441 |
| 2022-12-01 | Micallef Jacob Vincent (Chief Scientific Officer) | Buy | 32,339 | 2.13 | 71,883 |
| 2022-12-01 | Faulkes Martin Charles | Buy | 55,000 | 2.10 | 115,500 |
| 2022-11-01 | Butera Salvatore Thomas (CEO - Volition Veterinary) | Buy | 5,000 | 2.21 | 11,050 |
| 2022-09-01 | Micallef Jacob Vincent (Chief Scientific Officer) | Buy | 13,000 | 1.70 | 22,100 |
| 2022-08-01 | Butera Salvatore Thomas (CEO - Volition Veterinary) | Buy | 10,000 | 1.62 | 16,200 |
| 2022-08-01 | Micallef Jacob Vincent (Chief Scientific Officer) | Buy | 29,000 | 1.74 | 50,460 |
| 2022-08-01 | Innes Guy Archibald | Buy | 312,500 | 2.00 | 625,000 |
| 2022-08-01 | Reynolds Cameron John (President and CEO) | Buy | 3,500 | 1.61 | 5,635 |
| 2022-06-01 | Butera Salvatore Thomas (CEO - Volition Veterinary) | Buy | 10,000 | 2.05 | 20,500 |
| 2022-06-01 | Terrell Jason Bradley Md (Chief Medical Officer) | Sale | 14,949 | 2.47 | 36,924 |
| 2022-05-01 | Innes Guy Archibald | Buy | 10,000 | 2.37 | 23,700 |
| 2022-04-01 | Terrell Jason Bradley Md (Chief Medical Officer) | Sale | 10,000 | 2.75 | 27,500 |
| 2021-11-01 | Butera Salvatore Thomas (CEO-Volition Veterinary) | Buy | 10,000 | 4.02 | 40,199 |
| 2021-05-28 | Terrell Jason Bradley Md (Chief Medical Officer) | Sale | 10,000 | 3.54 | 35,400 |
| 2021-05-17 | Innes Guy Archibald (Director) | Buy | 50,000 | 3.47 | 173,500 |
| 2021-05-14 | Nguyen Kim (Director) | Buy | 2,000 | 3.20 | 6,400 |
| 2021-05-14 | Innes Guy Archibald (Director) | Buy | 100,000 | 3.29 | 329,000 |
| 2021-02-05 | Terrell Jason Bradley Md (Chief Medical Officer) | Sale | 10,000 | 5.37 | 53,700 |
| 2020-12-02 | Terrell Jason Bradley Md (Chief Medical Officer) | Sale | 10,000 | 3.40 | 34,000 |
| 2020-11-18 | Terrell Jason Bradley Md (Chief Medical Officer) | Sale | 3,429 | 3.40 | 11,658 |
| 2020-11-17 | Terrell Jason Bradley Md (Chief Medical Officer) | Sale | 1,571 | 3.40 | 5,341 |
| 2020-09-18 | Terrell Jason Bradley Md (Chief Medical Officer) | Option Ex | 25,000 | 2.47 | 61,750 |
| 2020-09-15 | Terrell Jason Bradley Md (Chief Medical Officer) | Sale | 19,500 | 3.23 | 62,985 |
| 2020-09-09 | Faulkes Martin Charles (Director) | Sale | 65,000 | 3.21 | 208,650 |
| 2020-08-17 | Gaetan Michel (Other) | Option Ex | 5,000 | 2.75 | 13,750 |
| 2020-08-12 | Innes Guy Archibald (Director) | Option Ex | 30,000 | 2.75 | 82,500 |
| 2020-08-10 | Micallef Jacob Vincent (Chief Scientific Officer) | Option Ex | 130,000 | 2.75 | 357,500 |
| 2020-08-04 | Terrell Jason Bradley Md (Chief Medical Officer) | Option Ex | 25,000 | 2.75 | 68,750 |
| 2020-07-21 | Rootsaert Rodney Gerard (Secretary) | Option Ex | 60,000 | 2.75 | 165,000 |
| 2020-07-21 | Faulkes Martin Charles (Director) | Option Ex | 60,000 | 2.75 | 165,000 |
| 2020-07-21 | Reynolds Cameron John (President and CEO) | Option Ex | 100,000 | 2.75 | 275,000 |
| 2020-05-22 | Reynolds Cameron John (President and CEO) | Buy | 4,000 | 2.75 | 11,000 |
| 2019-12-05 | Reynolds Cameron John (President and CEO) | Buy | 1,100 | 4.24 | 4,664 |
| 2019-10-01 | Cotterford Co Ltd (10% Owner) | Buy | 50,000 | 5.69 | 284,550 |
| 2019-09-26 | Cotterford Co Ltd (10% Owner) | Sale | 46,238 | 6.03 | 278,815 |
| 2019-08-27 | Faulkes Martin Charles (Director) | Buy | 10,000 | 3.75 | 37,500 |
| 2019-08-15 | Faulkes Martin Charles (Director) | Buy | 50,000 | 3.94 | 197,000 |
| 2019-06-11 | Faulkes Martin Charles (Director) | Buy | 79,269 | 3.12 | 247,319 |
| 2019-06-10 | Faulkes Martin Charles (Director) | Buy | 70,731 | 3.02 | 213,607 |
| 2018-08-16 | Innes Guy Archibald (Director) | Buy | 50,000 | 1.98 | 98,900 |
| 2018-08-16 | Rootsaert Rodney Gerard (Secretary) | Buy | 5,000 | 1.91 | 9,550 |
| 2018-08-16 | Reynolds Cameron John (President and CEO) | Buy | 6,500 | 1.91 | 12,415 |
| 2017-09-19 | Vanston David Cecil (CHIEF FINANCIAL OFFICER) | Buy | 2,750 | 2.84 | 7,810 |
| 2017-08-16 | Rootsaert Rodney Gerard (Secretary) | Buy | 3,630 | 2.77 | 10,055 |
| 2017-08-16 | Reynolds Cameron John (President and CEO) | Buy | 3,630 | 2.77 | 10,055 |
| 2016-11-25 | Faulkes Martin Charles (Director) | Option Ex | 5,000 | 3.00 | 15,000 |
| 2016-11-22 | Colman Alan (Director) | Option Ex | 5,000 | 3.00 | 15,000 |
| 2016-11-18 | Micallef Jacob Vincent (Chief Scientific Officer) | Option Ex | 20,000 | 3.00 | 60,000 |
| 2016-11-18 | Innes Guy Archibald (Director) | Option Ex | 5,000 | 3.00 | 15,000 |
| 2016-11-18 | Rootsaert Rodney Gerard (Secretary) | Option Ex | 10,000 | 3.00 | 30,000 |
| 2016-11-18 | Reynolds Cameron John (President and CEO) | Option Ex | 20,000 | 3.00 | 60,000 |
| 2016-11-11 | Skaff Habib (Director) | Option Ex | 4,000 | 3.00 | 12,000 |
| 2016-10-05 | Kratochvil David Matthew (Chief Financial Officer) | Buy | 10,000 | 5.00 | 50,000 |
| 2016-05-25 | Faulkes Martin Charles (Director) | Option Ex | 5,000 | 3.00 | 15,000 |
| 2016-05-20 | Micallef Jacob Vincent (Chief Scientific Officer) | Option Ex | 20,000 | 3.00 | 60,000 |
| 2016-05-20 | Skaff Habib (Director) | Option Ex | 4,000 | 3.00 | 12,000 |
| 2016-05-20 | Innes Guy Archibald (Director) | Option Ex | 5,000 | 3.00 | 15,000 |
| 2016-05-20 | Rootsaert Rodney Gerard (Secretary) | Option Ex | 10,000 | 3.00 | 30,000 |
| 2016-05-20 | Colman Alan (Director) | Option Ex | 5,000 | 3.00 | 15,000 |
| 2016-05-20 | Reynolds Cameron John (President and CEO) | Sale | 3,390 | 3.54 | 12,000 |
| 2016-05-20 | Reynolds Cameron John (President and CEO) | Option Ex | 20,000 | 3.00 | 60,000 |
| 2016-03-29 | Colman Alan (Director) | Option Ex | 100,000 | .50 | 50,000 |
| 2016-03-22 | Innes Guy Archibald (Director) | Option Ex | 100,000 | .50 | 50,000 |
| 2015-12-09 | Micallef Jacob Vincent (Chief Scientific Officer) | Option Ex | 50,000 | 3.01 | 150,500 |
| 2015-05-15 | Reynolds Cameron John (President and CEO) | Buy | 1,500 | 3.37 | 5,047 |
| 2015-02-11 | Innes Guy Archibald (Director) | Buy | 50,000 | 3.75 | 187,500 |
Insider trading activities including stock purchases, stock sales, and option exercises of VNRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Volitionrx Ltd (symbol VNRX, CIK number 93314) see the Securities and Exchange Commission (SEC) website.